These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 26468185)

  • 1. Chaperones in Neurodegeneration.
    Lindberg I; Shorter J; Wiseman RL; Chiti F; Dickey CA; McLean PJ
    J Neurosci; 2015 Oct; 35(41):13853-9. PubMed ID: 26468185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular chaperones and neuronal proteostasis.
    Smith HL; Li W; Cheetham ME
    Semin Cell Dev Biol; 2015 Apr; 40():142-52. PubMed ID: 25770416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.
    Sinnige T; Yu A; Morimoto RI
    Adv Exp Med Biol; 2020; 1243():53-68. PubMed ID: 32297211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteostasis and the Regulation of Intra- and Extracellular Protein Aggregation by ATP-Independent Molecular Chaperones: Lens α-Crystallins and Milk Caseins.
    Carver JA; Ecroyd H; Truscott RJW; Thorn DC; Holt C
    Acc Chem Res; 2018 Mar; 51(3):745-752. PubMed ID: 29442498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Chaperone/Co-Chaperone Interactions with Small Molecules: A Novel Approach to Tackle Neurodegenerative Diseases.
    Wang L; Bergkvist L; Kumar R; Winblad B; Pavlov PF
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular chaperones and protein folding as therapeutic targets in Parkinson's disease and other synucleinopathies.
    Ebrahimi-Fakhari D; Saidi LJ; Wahlster L
    Acta Neuropathol Commun; 2013 Dec; 1(1):79. PubMed ID: 24314025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular chaperones biochemistry and role in neurodegenerative diseases.
    Chaari A
    Int J Biol Macromol; 2019 Jun; 131():396-411. PubMed ID: 30853582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNAJ Proteins in neurodegeneration: essential and protective factors.
    Zarouchlioti C; Parfitt DA; Li W; Gittings LM; Cheetham ME
    Philos Trans R Soc Lond B Biol Sci; 2018 Jan; 373(1738):. PubMed ID: 29203718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of neurodegeneration by molecular chaperones.
    Muchowski PJ; Wacker JL
    Nat Rev Neurosci; 2005 Jan; 6(1):11-22. PubMed ID: 15611723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsp90 and Its Co-Chaperones in Neurodegenerative Diseases.
    Bohush A; Bieganowski P; Filipek A
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The disturbance of protein synthesis/degradation homeostasis is a common trait of age-related neurodegenerative disorders.
    Di Domenico F; Lanzillotta C
    Adv Protein Chem Struct Biol; 2022; 132():49-87. PubMed ID: 36088079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein aggregation in cell biology: An aggregomics perspective of health and disease.
    Cox D; Raeburn C; Sui X; Hatters DM
    Semin Cell Dev Biol; 2020 Mar; 99():40-54. PubMed ID: 29753879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-misfolding diseases and chaperone-based therapeutic approaches.
    Chaudhuri TK; Paul S
    FEBS J; 2006 Apr; 273(7):1331-49. PubMed ID: 16689923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular protein homeostasis in neurodegenerative diseases.
    Wilson MR; Satapathy S; Vendruscolo M
    Nat Rev Neurol; 2023 Apr; 19(4):235-245. PubMed ID: 36828943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic Insights into the Role of Molecular Chaperones in Protein Misfolding Diseases: From Molecular Recognition to Amyloid Disassembly.
    Hervás R; Oroz J
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secreted Chaperones in Neurodegeneration.
    Chaplot K; Jarvela TS; Lindberg I
    Front Aging Neurosci; 2020; 12():268. PubMed ID: 33192447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Chemical Biology of Molecular Chaperones--Implications for Modulation of Proteostasis.
    Brandvold KR; Morimoto RI
    J Mol Biol; 2015 Sep; 427(18):2931-47. PubMed ID: 26003923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of HSP70 and its co-chaperones in protein misfolding, aggregation and disease.
    Duncan EJ; Cheetham ME; Chapple JP; van der Spuy J
    Subcell Biochem; 2015; 78():243-73. PubMed ID: 25487025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model systems of protein-misfolding diseases reveal chaperone modifiers of proteotoxicity.
    Brehme M; Voisine C
    Dis Model Mech; 2016 Aug; 9(8):823-38. PubMed ID: 27491084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.